Mechanisms of action | Frequency |
---|---|
Inhibit CYP3A4a | 78 |
Induce hepatic CYP3A4 | 13 |
Induce intestinal CYP3A4 | 13 |
Inhibit hepatic CYP3A4 | 13 |
Inhibit intestinal CYP3A4 | 13 |
Decrease gastrointestinal transit time | 11 |
Induce CYP3A4 | 9 |
Increase hepatotoxicity of the drug | 8 |
Inhibit P-gpb | 6 |
Inhibit OATP1A2 c | 4 |
Inhibit OATP1B1 d | 4 |
Inhibit OATP2B1 e | 4 |
Stimulate or suppress the immune function | 4 |
Inhibit CYP2C9 f | 3 |
Inhibit CYP2C19 g | 2 |
Potential estrogenic effects of herbs | 2 |
Inhibit UGT2B7 h | 2 |
Inhibit UGT1A1 i | 2 |
increase photosensitivity of drug | 2 |
Inhibit or induce CYP2D6 j | 2 |
Enhances the oral bioavailability of drug | 1 |
Inhibit CYP1A2 k | 1 |
Inhibit CYP2C8 l | 1 |
Block proteasome inhibitor | 1 |